October 2025
1. TODESCO E, Valantin MA, Akhavan S, Rouget R, et al
   Acute hepatitis B infections among PWH treated with 2-drug regimen: can we trust the vaccination status?
   AIDS. 2025;39:1845-1847.
   

   >> Share

   
   September 2025
2. GENER AR
   Balanced HPV vaccination campaigns should include all sexes, genders before and after commencement of sexual activity.
   AIDS. 2025;39:1661-1662.
   

   >> Share

   
   March 2025
3. LIN LY, Ferte T, Chachage M, Casteano C, et al
   Deciphering HIV vaccine-induced Antibody response according to ethnicity.
   AIDS. 2025 Mar 31. doi: 10.1097/QAD.0000000000004196.
   

   >> Share

   
   
4. LUCEY M, Burns F, Bhagani S, Lipman M, et al
   SARS-CoV-2 antibody prevalence in adults living with HIV.
   AIDS. 2025 Mar 13. doi: 10.1097/QAD.0000000000004180.
   

   >> Share

   
   February 2025
5. WIESMANN C, Conway B
   The challenge of normalizing vaccine behaviors in the postpandemic era.
   AIDS. 2025;39:206-207.
   

   >> Share

   
   December 2024
6. BERING L, Heftdal LD, Heidari SL, Hamm SR, et al
   Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes.
   AIDS. 2024;38:2100-2103.
   

   >> Share

   
   November 2024
7. AUGELLO M, Bono V, Rovito R, Santoro A, et al
   Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV.
   AIDS. 2024;38:1987-1990.
   

   >> Share

   
   
8. FRIEDMAN MR, Wingood G, Krause KD, Krier S, et al
   Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed-serostatus cohort.
   AIDS. 2024 Nov 5. doi: 10.1097/QAD.0000000000004053.
   

   >> Share

   
   October 2024
9. SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al
   The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.
   AIDS. 2024 Oct 11. doi: 10.1097/QAD.0000000000004038.
   

   >> Share

   
   
10. SIREGAR T, Weriditi RK, Reba YA, Muttaqin MZ, et al
    Impact of COVID-19 vaccination on HIV parameters in people with HIV on antiretroviral therapy.
    AIDS. 2024;38:1807-1808.
    

    >> Share

    
    August 2024
11. LINFIELD RY, Slusky DJG, Moskatel LS
    The impact of Mpox virus incidence and Mpox virus first-dose vaccination on recent HIV testing.
    AIDS. 2024;38:1595-1597.
    

    >> Share

    
    July 2024
12. 
    Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV: Erratum.
    AIDS. 2024;38:1279.
    

    >> Share

    
    May 2024
13. JONGKEES MJ, Tan NH, Geers D, de Vries RD, et al
    Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
    AIDS. 2024 May 24. doi: 10.1097/QAD.0000000000003933.
    

    >> Share

    
    April 2024
14. FRESSE A, Massy N, Fournier D, Pinel S, et al
    Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.
    AIDS. 2024;38:768-771.
    

    >> Share

    
    March 2024
15. GIANELLA S, Anderson C, Chaillon A, Wells A, et al
    Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy.
    AIDS. 2024 Mar 25. doi: 10.1097/QAD.0000000000003882.
    

    >> Share

    
    December 2023
16. KEBEDE S, Brazier E, Freeman AM, Muwonge TR, et al
    PrEP Availability Among Health Facilities Participating in the Global IeDEA Consortium.
    AIDS. 2023 Dec 22. doi: 10.1097/QAD.0000000000003824.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share